Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LXGTF SOLUTION: EARLY DETECTION
The only way to detect that arteries are vulnerable to
atherosclerosis is to assess endothelial function. This is a
test of the endothelial cells that line all the arteries in the body.
The endothelium is the single layer of cells that line various
organs and cavities, especially the heart, blood and lymphatic
vessels. These cells act as a shield, preventing plaque from
forming inside the artery wall, and produce substances that
stop blood clots from developing in the vessel.
Healthy endothelial cells release nitric oxide (NO), which
is responsible for most of the protective functions of these
cells in the artery.
In an at-risk individual, the endothelial cells do not
produce enough NO, or the NO produced is deactivated
by chemicals in the bloodstream before it can prevent
deposits from forming in the arterial wall.
PROBLEM: HEART DISEASE IS A KILLER No.1
Nearly 1 in 3 deaths in the USA are caused by heart
disease and stroke. Of the approximately 1.5 million
people suffering heart attacks annually in the U.S., more
than 250,000 will die within one hour of their incident.
Nearly 1/3 of the ~ 600,000 annual cardiovascular
disease deaths in the U.S. could be prevented through
changes in lifestyle habits. Unfortunately, for up to 50%
of these individuals, the FIRST SYMPTOM of coronary
artery disease is sudden cardiac death, or a heart attack.
-Source: World Health Organization / Center for Disease
Control (CDC) Atlanta
WHAT is LXGTF IN SHORT? Revolutionary Cardiovascular Health Monitoring Developers of a simple and effective personal vascular health device for early identification of heart disease.
Hello everybody, we looking for the last green week this year!
Runner with golden shoes
Not counting a breaktrough jump FDA
This will be great, of not it will be sure early january
The winner of the 2018!
This is LXGTF gran finale of the 2017
Green +7.8. Like this final week
Green power hour, just walk trough in the new year!
Right, people must do larger dd to understand this great opportunity here
Great move
Ohh yes Maltz is super smart!
Right is a time field in a certain time field which is short term for sure
Going green
Here is important to see the opportunity to can have the cream of the cake soon.
Me too
LXGTF will close green today and looking for a breaktroug before New year.
ONLY LXGTF have the SOLUTION!!! Early assessment is key to prevention through
proactive lifestyle modification, physician care and
ongoing monitoring. However, blood pressure and
cholesterol monitoring are only partial indicators of
cardiovascular health. Most cardiovascular disease
is related to plaque buildup and inflammation within the
arteries (atherosclerosis).
SOLUTION: EARLY DETECTION
WOW! By 2020, $2.6 billion Global monitoring instruments market
will increasingly shift to the high-growth home segment.
HeartSentry™ has been developed to measure the
function of the endothelium, the cells that line all
arteries and are critical to the prevention of
atherosclerosis, heart attacks and stroke.
Power hour time, green entrance!
Yep looking for a nice year closure
Thanks for this
GOOD PLAN, Things in progress! Development Plan
• Develop regulatory plan and meet with FDA to confirm
• Create test platform for algorithm development
• Establish scientific advisory board
• Create quality system
• Identify and sign contract with manufacturing partner
• Manufacture units
• Acute calibration study
• Clinical study comparing cFMD to uFMD (or
other standard) and show positive correlation
• Submit for FDA approval with calibration study data
TEAM: EXPERT LEADERSHIP
The principals, directors and advisors of Lexington
BioSciences have been individually and collectively
involved in raising extensive capital funding for their
private and public companies. Team members have held
numerous executive leadership positions encompassing
biotechnology, and medical device companies, as well as
multi-national corporations. The team includes inventors,
scientists, and business people who have successfully
started, built and grown multiple life science companies.
THINGS ARE MOVING FAST! Lexington's President Eric Willis comments, "As recently announced, we are moving ahead quickly towards the commencement of our HeartSentry pilot clinical research study designed to build the foundational dataset ultimately aimed at supporting FDA clearance. As we plan for market entry, we know that a key element to commercial success will come from fielding a product that meets the threshold for medical insurance coverage. Regulatory approval rarely guarantees payment coverage for new devices, so we are undertaking what we believe is the prudent strategy of beginning that process today. We are delighted to have the opportunity to work with the Navigant team and feel certain the advice and direction we receive will prove invaluable towards providing HeartSentry the best strategy for market introduction."
LXGTF Article by Jonathan Maltz, "What is Endothelial Function..." : https://lexingtonbiosciences.com/news/endothelial-function-important-health/
Thank you Blockchain, good to see you!
Wow amazing to see this green start!
The Company also stated that recent developments in the crypto retail space are very encouraging as they pointed to the recent ICO and news releases issued by Overstock.com (NASDAQ:OSTK). Overstock.com, through their subsidiary, tZERO, has launched their own Security Token Sale and are considering benefits of token holders including the possibility of discounted merchandise and even free membership in Overstock's rewards program. Overstock CEO Patrick Byrne said: "Overstock is proud to be the market-leading enterprise embracing the cryptorevolution. Recognizing the blockchain technology-driven transformation and disruption already underway across numerous industries, Overstock today opens the tZERO ICO."
Hello everybody, good to see you! Happy holidays!
Thank you SuperPac, same to you.
This video must be watched! Great!
Thank you Italian, same to you!
WHY LXGTF is better? Knowing the core health of the cardiovascular
system is critical to
preventing future heart attacks and strokes
• Monitoring cardiovascular health changes over time is key to prevention via
lifestyle modification, physician care and ongoing monitoring.
• Traditional measures of blood pressure and cholesterol measurements are only
partial indicators of cardiovascular health.
This is BIG: Blood pressure monitor market forecast to exceed $2.6 billion by 2020
LXGTF simplify and save lifes! Current Standards are Complicated and Expensive!!!
• Gold standard - ULTRASOUND
• Measurement directly views arterial diameter changes
• Only at specialized diagnostic centers
• Requires trained ultrasonographer
• Expensive capital equipment needed
• Alternative method - ENDOPAT
• Measurement uses a fingertip blood oxygen
sensor and laptop computer.
• Only at specialized diagnostic centers
• Requires trained technician
Currently only used in specialized research centers by highly trained staff
__________
What we can see today. I am exited about this last week in 2017.
Hello merry Christmass and blessed holidays!
right I am in both modes in the last few days and is crazy lol